These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1892341)

  • 1. Renal insufficiency and secondary hyperparathyroidism in elderly patients.
    Turner G; Brown RC; Silver A; Seymour G; Woodhead JS
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():321-6. PubMed ID: 1892341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study.
    Carter JL; O'Riordan SE; Eaglestone GL; Delaney MP; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3554-65. PubMed ID: 18544628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
    St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
    Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
    Portale AA; Morris RC
    Miner Electrolyte Metab; 1991; 17(4):211-20. PubMed ID: 1813783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
    Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
    Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
    Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
    Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of the serum concentration of 1,25-dihydroxyvitamin D in primary hyperparathyroidism.
    Lalor BC; Mawer EB; Davies M; Lumb GA; Hunt L; Adams PH
    Clin Sci (Lond); 1989 Jan; 76(1):81-6. PubMed ID: 2537704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of 25-hydroxyvitamin D and its association with bone mineral density and serum parathyroid hormone levels during winter in urban males from Guiyang, Southwest China.
    Zhang Q; Shi L; Peng N; Xu S; Zhang M; Zhang S; Li H; Zhuang H; Gong M; Wu D; Wang R
    Br J Nutr; 2016 Mar; 115(6):960-6. PubMed ID: 26843386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA; Booth BE; Halloran BP; Morris RC
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
    Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
    Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
    Messa P; Mioni G; Turrin D; Guerra UP
    Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum intact parathyroid hormone levels in elderly patients with hip fracture.
    Compston JE; Silver AC; Croucher PI; Brown RC; Woodhead JS
    Clin Endocrinol (Oxf); 1989 Dec; 31(6):667-72. PubMed ID: 2627757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency.
    Llach F; Massry SG
    J Clin Endocrinol Metab; 1985 Oct; 61(4):601-6. PubMed ID: 2993340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease.
    Davies M; Heys SE; Selby PL; Berry JL; Mawer EB
    J Clin Endocrinol Metab; 1997 Jan; 82(1):209-12. PubMed ID: 8989260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.